Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcoma

por Ghilu, Samson, Morton, Christopher L., Vaseva, Angelina V., Zheng, Siyuan, Kurmasheva, Raushan T., Houghton, Peter J.
Publicado 2022

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

por Odeniyide, Patience, Yohe, Marielle E., Pollard, Kai, Vaseva, Angelina V., Calizo, Ana, Zhang, Lindy, Rodriguez, Fausto J., Gross, John M., Allen, Amy N., Wan, Xiaolin, Somwar, Romel, Schreck, Karisa C., Kessler, Linda, Wang, Jiawan, Pratilas, Christine A.
Publicado 2022

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

por Odeniyide, Patience, Yohe, Marielle E., Pollard, Kai, Vaseva, Angelina V., Calizo, Ana, Zhang, Lindy, Rodriguez, Fausto J., Gross, John M., Allen, Amy N., Wan, Xiaolin, Somwar, Romel, Schreck, Karisa C., Kessler, Linda, Wang, Jiawan, Pratilas, Christine A.
Publicado 2022